Ercros has completed the expansion of the chlorine-caustic soda plant in Vila-seca I
Barcelona - According to the Act Plan announced by Ercros, the company has completed the third expansion of the capacity of the chlorine and caustic soda production plant at the Vila-seca I factory, with the starting up of a new electrolyzer that expands the capacity of the plant by another 26,000 t/year.
After this expansion, Ercros total chlorine production capacity is 217,000 t/year (172,000 t/year at the Vila-seca I factory and 45,000 t/year at the Sabiñánigo factory), which consolidates the company as the first Spanish and ninth European manufacturer of chlorine and caustic soda.
With the three extensions carried out between 2017 and 2019, Ercros’ real chlorine and caustic soda production has recovered the level it had before the cessation of mercury technology, following the European ban on using mercury in the chlor-alkali plants. Currently, Ercros manufactures all the chlorine and caustic soda using membrane technology, which is considered the best available technology (BAT).
Categories
Investments
Countries
Companies
Latest news
INEOS launches €250m investment supported by the French Government to secure the future of French industry at Lavera
The project marks the first phase of a long-term regeneration plan to reduce emissions, boost reliability, efficiency and competitiveness, with support of the French State.
Hycamite’s technology to decarbonize shipping awarded AiP by industry leader DNV
Kokkola Industrial Park →Hycamite’s proprietary Thermo-Catalytic Decomposition (TCD) technology offers a new approach to producing clean hydrogen by breaking down methane, the primary component of liquefied natural gas (LN...
Clariant catalysts will power the Ecoplanta: Europe's first waste-to-methanol plant
Chemmed Cluster Tarragona →Repsol is building Europe’s first plant to produce renewable methanol from urban waste The facility will use Enerkem gasification technology to produce 240 KTA of methanol Clariant will supply cata...
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
